ConductScience.org, home

Trial · NCT00798018

Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena

NCT00798018, Not applicable, Completed, Sichuan University; results first posted 2009-12-18

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena. Trials, record NCT00798018. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00798018

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena
NCT number
NCT00798018
Status
Completed
Phases
Not applicable
Enrollment
100 participants, actual
Lead sponsor
Sichuan University
Conditions
Pharyngitis
Interventions
2% lidocaine, placebo, 1% tetracaine, N.S
First posted
2008-11-25
Last updated
2009-12-18
Results first posted
2009-12-18

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryVisual Analogue Scale(0-100mm) by the Subject.6 hours, 12 hours, 24 hours, 48 hours after extubation
visual analogue scale (VAS) was used to evaluate the post-intubation sore throat. The VAS was a well-recongnized standard tool for rating of pain. The VAS measures exactly 100 mm. 0 means no pain and 100 means the worst pain that one can image. Patient marks a point on the line that matches the amount of pain he or she feels.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYVisual Analogue Scale(0-100mm) by the Subject.6 hours, 12 hours, 24 hours, 48 hours after extubationmmMEAN

Results by group16

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Visual Analogue Scale(0-100mm) by the Subject.Air Alone6h51Standard Deviation 37mm
Visual Analogue Scale(0-100mm) by the Subject.Normal Saline6h40Standard Deviation 31mm
Visual Analogue Scale(0-100mm) by the Subject.Lidocaine6h22Standard Deviation 17mm
Visual Analogue Scale(0-100mm) by the Subject.Tetracaine6h9Standard Deviation 8mm
Visual Analogue Scale(0-100mm) by the Subject.Air Alone12h50Standard Deviation 33mm
Visual Analogue Scale(0-100mm) by the Subject.Normal Saline12h38Standard Deviation 19mm
Visual Analogue Scale(0-100mm) by the Subject.Lidocaine12h25Standard Deviation 15mm
Visual Analogue Scale(0-100mm) by the Subject.Tetracaine12h13Standard Deviation 7mm
Visual Analogue Scale(0-100mm) by the Subject.Air Alone24h43Standard Deviation 39mm
Visual Analogue Scale(0-100mm) by the Subject.Normal Saline24h41Standard Deviation 30mm

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDAir Alone25
Overall StudySTARTEDNormal Saline25
Overall StudySTARTEDLidocaine25
Overall StudySTARTEDTetracaine25
Overall StudyCOMPLETEDAir Alone25
Overall StudyCOMPLETEDNormal Saline25
Overall StudyCOMPLETEDLidocaine25
Overall StudyCOMPLETEDTetracaine25
Overall StudyNOT COMPLETEDAir Alone0
Overall StudyNOT COMPLETEDNormal Saline0

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals12

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityAir Alone
Total, all-cause mortalityNormal Saline
Total, all-cause mortalityLidocaine
Total, all-cause mortalityTetracaine
Total, other adverse eventsAir Alone025
Total, other adverse eventsNormal Saline025
Total, other adverse eventsLidocaine025
Total, other adverse eventsTetracaine025
Total, serious adverse eventsAir Alone025
Total, serious adverse eventsNormal Saline025

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
14970135BACKGROUND

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00798018

GET https://conductscience.org/api/trials/v1/NCT00798018/registered